Company | TransDigm Group Incorporated |
Ticker | TDG (NYSE) |
Upcoming Earnings | Q3 FY2026 — August 4, 2026 |
Last Reported | Q2 FY2026 — May 5, 2026 |
Prepared | August 3, 2026 |
Sector ETF Benchmark | ITA (iShares U.S. Aerospace & Defense ETF) |
Key Takeaway: The setup into Q3 FY2026 is constructive — consensus sits below the raised full-year guidance run-rate, and the biggest swing factor is whether commercial aftermarket momentum sustained through the Middle East conflict disruption.
Bar: Consensus for Q3 FY2026 net sales of ~$2.67B and EBITDA As Defined of ~$1.40B implies roughly 19% and 15% YoY growth, respectively — a meaningful step-up from Q2 actuals but consistent with the raised full-year guidance midpoint of $10.36B in revenue and $5.42B in EBITDA. The bar is achievable but not low; management's own guidance implies Q3 must be the strongest quarter of the year on an absolute basis.
Guidance/Tone: Management raised full-year guidance materially at Q2 (revenue midpoint +$420M, EBITDA +$210M, EPS to $39.52, FCF to ~$2.5B) and struck a confident tone on base business outperformance. The Stellant withdrawal (July 13) removes a regulatory overhang and frees capital, while the Prince & Izant acquisition announcement (July 27, $1.07B) signals continued M&A discipline. Tone has shifted from cautious on Middle East to measured confidence — management noted historical disruptions of this type are "sharp and self-correcting."
Estimate Trajectory: Post-Q2 earnings, consensus estimates for Q3 FY2026 net sales moved from ~$2.66B to ~$2.67B and EBITDA As Defined from ~$1.39B to ~$1.40B — modest upward drift tracking the guidance raise. Full-year FY2026 EPS consensus of ~$40.00 sits just above the guidance midpoint of $39.52, suggesting the street is giving slight credit for further outperformance. Revisions are constructive but not aggressive, leaving room for a positive surprise.
Stock Setup: TDG is up ~+8% since the Q2 print (indexed basis) vs. ITA +14% and SPY +5%, meaning the stock has lagged the sector ETF despite strong fundamentals — partly reflecting the Stellant withdrawal overhang and the mid-July selloff. At ~$1,285, TDG trades at roughly 23x forward EBITDA, near the high end of its historical range but below some aftermarket peers. The stock has not fully priced in a beat, creating asymmetric upside if commercial aftermarket growth holds.
Wildcard: The single biggest swing factor is commercial aftermarket trajectory through the Middle East conflict. Q2 CAM bookings were an all-time high, but management flagged RPM deceleration in March/April and slightly negative Middle East takeoff/landing cycles. If Q3 CAM revenue comes in at the high end of the high-single-digit to low-double-digit guidance range (or above), the stock should re-rate higher. Conversely, any commentary suggesting the conflict is weighing on Q4 CAM ordering would be the key downside risk.
Key Takeaway: Consensus for Q3 FY2026 reflects a high but achievable bar — double-digit growth across all three channels is baked in. Commercial Aftermarket revenue is the bigger swing factor; defense has been consistently beating while CAM carries the most uncertainty given Middle East dynamics.
KPI | Q2 FY2026 Actual | Q3 FY2025 Actual | Q3 FY2026 Consensus Est. | YoY Change | FY2026 Guidance (Midpoint) | Cons. vs. Guidance |
Net Sales ($M) | $2,544 | $2,237 | $2,675 | +19.6% | $10,360M (FY) | On track |
Commercial Aftermarket Revenue ($M) | $839 | $695 | $837 | +20.4% | High-SD to Low-DD% | ~+20% vs. prior yr |
Commercial OEM Revenue ($M) | $603 | $539 | $639 | +18.6% | Low-DD to Mid-Teens% | ~+19% vs. prior yr |
Defense Revenue ($M) | $1,057 | $963 | $1,081 | +12.3% | High-SD% | ~+12% vs. prior yr |
EBITDA As Defined ($M) | $1,337 | $1,217 | $1,400 | +15.0% | $5,420M (FY) | On track |
EBITDA As Defined Margin (%) | 52.6% | 54.4% | 52.3% | -210 bps YoY | ~52.3% (FY) | In line |
Adj. EPS — Diluted ($) | $9.85 | $9.60 | $10.27 | +7.0% | $39.52 (FY midpoint) | ~+2% above midpoint |
Free Cash Flow ($M) | $64 | $573 | $636 | +10.9% | ~$2,500M (FY) | On track |
Source: Visible Alpha Consensus and Actuals Data. Q3 FY2026 consensus as of August 3, 2026. FY2026 guidance from Q2 FY2026 earnings call (May 5, 2026). EBITDA As Defined = EBITDA – Operating (TransDigm’s non-GAAP measure). Margin YoY decline reflects acquisition dilution (~200 bps) from Jet Parts Engineering, Victor Sierra, and other recently closed deals; base business margins continue to expand.
Quarter | Reported ($M) | Consensus ($M) | Surprise % | Result |
Q2 FY2026 | $2,544 | $2,467 | +3.1% | Beat |
Q1 FY2026 | $2,285 | $2,258 | +1.2% | Beat |
Q4 FY2025 | $2,437 | $2,400 | +1.5% | Beat |
Q3 FY2025 | $2,237 | $2,301 | -2.8% | Miss |
Q2 FY2025 | $2,150 | $2,165 | -0.7% | Miss |
Q1 FY2025 | $2,006 | $2,036 | -1.5% | Miss |
Q4 FY2024 | $2,185 | $2,145 | +1.9% | Beat |
Q3 FY2024 | $2,046 | $2,004 | +2.1% | Beat |
Quarter | Reported ($M) | Consensus ($M) | Surprise % | Result |
Q2 FY2026 | $1,337 | $1,297 | +3.1% | Beat |
Q1 FY2026 | $1,197 | $1,176 | +1.8% | Beat |
Q4 FY2025 | $1,320 | $1,293 | +2.1% | Beat |
Q3 FY2025 | $1,217 | $1,226 | -0.7% | Miss |
Q2 FY2025 | $1,162 | $1,152 | +0.9% | Beat |
Q1 FY2025 | $1,061 | $1,055 | +0.6% | Beat |
Q4 FY2024 | $1,149 | $1,117 | +2.9% | Beat |
Q3 FY2024 | $1,091 | $1,056 | +3.3% | Beat |
Pattern: TDG has beaten EBITDA As Defined consensus in 7 of the last 8 quarters, with the sole miss (Q3 FY2025) driven by distributor destocking headwinds that have since resolved. Revenue beats have been less consistent (5 of 8), with misses concentrated in the destocking period (Q1–Q3 FY2025). The recent trend (last 3 quarters) is a clean beat streak on both KPIs, setting a high but credible bar for Q3 FY2026.
Source: Visible Alpha Consensus and Actuals Data.
Key Takeaway: Management raised full-year FY2026 guidance materially at Q2 earnings (May 5), with the large majority of the raise driven by base business outperformance rather than acquisitions. No further formal guidance revisions have been issued since Q2 earnings; the Stellant withdrawal (July 13) and Prince & Izant announcement (July 27) are capital allocation events, not guidance changes.
Metric | Initial Guidance (Q2 FY2026 Earnings Call, May 5, 2026) | Revised Guidance | Current Consensus | Note |
FY2026 Net Sales | $10.31B–$10.41B (midpoint $10.36B) | — | $10.38B | No post-Q2 revision; consensus ~$20M above midpoint, reflecting slight outperformance credit |
FY2026 EBITDA As Defined | ~$5.42B (midpoint); ~52.3% margin | — | $5.44B | No post-Q2 revision; consensus ~$20M above midpoint |
FY2026 Adj. EPS | $39.52 (midpoint) | — | $40.00 | No post-Q2 revision; consensus ~$0.48 above midpoint, implying street expects further beat |
FY2026 Free Cash Flow | ~$2.5B (raised from ~$2.4B at Q1) | — | $2.14B | Consensus below guidance midpoint; FCF is lumpy quarter-to-quarter; Q2 FCF was only $64M |
Commercial Aftermarket Growth | High-SD to Low-DD% (raised from High-SD%) | — | ~+20% YoY Q3 cons. | Middle East conflict flagged as key risk; Q2 CAM bookings were all-time high; management tone cautious but not alarmed |
Commercial OEM Growth | Low-DD to Mid-Teens% (raised from High-SD to Mid-Teens%) | — | ~+19% YoY Q3 cons. | Boeing 737 ramping to 47/month; bookings running well ahead of shipments; management encouraged |
Defense Growth | High-SD% (unchanged) | — | ~+12% YoY Q3 cons. | Strong bookings building backlog; defense budget tailwinds from bipartisan support for ~25% increase in 2027 budget |
M&A Capacity | >$10B remaining capacity | Stellant withdrawn (Jul 13); Prince & Izant announced ($1.07B, Jul 27) | N/A | ↑ Stellant withdrawal frees capital; Prince & Izant adds ~$360M revenue (CY2026); capacity remains substantial |
Key Takeaway: Estimates have drifted modestly higher since the Q2 print, tracking the guidance raise with a slight premium. The gap between consensus and guidance midpoint is small and constructive — the street is giving TDG modest outperformance credit without getting aggressive, leaving room for a positive surprise if Q3 CAM holds up.
KPI (Period) | Estimate at May 12, 2026 (+5 Days Post Q2 Print) | Current Consensus (Aug 3, 2026) | Estimate Δ (%) | Initial Guidance (Q2 Call, May 5) | Current Guidance | Guidance Δ | Cons. vs. Guidance (%) |
Net Sales — Q3 FY2026 | $2,662M | $2,675M | +0.5% | Implied by FY guide | Unchanged | — | ~+1% above implied |
Net Sales — FY2026 | $10,370M | $10,382M | +0.1% | $10,360M (midpoint) | Unchanged | — | +0.2% above midpoint |
EBITDA As Defined — Q3 FY2026 | $1,393M | $1,400M | +0.5% | Implied by FY guide | Unchanged | — | ~+1% above implied |
EBITDA As Defined — FY2026 | $5,439M | $5,444M | +0.1% | $5,420M (midpoint) | Unchanged | — | +0.4% above midpoint |
Adj. EPS — Q3 FY2026 | $10.20 | $10.27 | +0.7% | Implied by FY guide | Unchanged | — | ~+2% above implied |
Adj. EPS — FY2026 | $39.99 | $40.00 | +0.0% | $39.52 (midpoint) | Unchanged | — | +1.2% above midpoint |
Adj. EPS — FY2027 | $47.30 | $47.53 | +0.5% | No FY2027 guidance issued | N/A | — | N/A |
Free Cash Flow — FY2026 | $2,114M | $2,136M | +1.0% | ~$2,500M (guidance) | Unchanged | — | -14.6% below guidance |
Estimates have been stable-to-slightly-higher since the Q2 print, with no meaningful divergence from guidance. The FCF consensus gap vs. guidance (-14.6%) reflects the lumpiness of TDG’s FCF profile (Q2 FCF was only $64M) and the market’s conservatism on working capital timing; management’s $2.5B full-year target implies a very strong H2 FCF ramp. FY2027 EPS consensus of $47.53 implies ~19% growth, consistent with TDG’s long-term algorithm.
Source: Visible Alpha Consensus and Actuals Data. Baseline as of May 12, 2026 (5 trading days post Q2 print).
Key Takeaway: TDG has underperformed the sector ETF (ITA) since the Q2 print (+8% vs. ITA +14%), despite strong fundamentals — the gap reflects the Stellant withdrawal overhang and a mid-July selloff. The underperformance vs. ITA is sentiment-driven, not earnings-driven, and creates a potential catch-up opportunity if Q3 results confirm the base business trajectory.
TDG vs. ITA (iShares U.S. Aerospace & Defense ETF) vs. S&P 500 — Indexed to 100 at May 5, 2026 (Q2 FY2026 Earnings Date). Source: Stock Price Data.
Performance Summary (May 5 – Aug 4, 2026):
Key Takeaway: Peer commentary from Q2 2026 earnings calls (reported June–July 2026, covering the April–June quarter that overlaps with TDG’s Q3 FY2026) is broadly positive for TDG’s setup: commercial aftermarket demand is resilient and accelerating, OEM production rates are ramping, defense bookings are at record levels, and the Middle East disruption appears manageable and self-correcting. All four peers raised full-year guidance.
Note: All peer commentary below is from Q2 2026 earnings calls (reported May–July 2026), covering the calendar quarter ending June 2026 — which aligns with TDG’s Q3 FY2026 (April–June 2026). Only forward-looking commentary and current-quarter observations relevant to TDG’s end markets are included.
Read-Through: Strongly positive for TDG’s commercial aftermarket and defense channels.
Read-Through: Highly positive for TDG’s aftermarket and OEM channels; GE’s MRO capacity constraints are a direct demand signal for TDG’s proprietary engine components.
Read-Through: Positive for TDG’s commercial aftermarket; HEICO’s record results and demand commentary validate the aftermarket cycle, while its PMA business is a competitive consideration for TDG.
Read-Through: Positive for TDG’s engine aftermarket and OEM channels; Howmet’s engine spares commentary is the most direct read-through for TDG’s engine-content products.
Read-Through: Mixed but net positive for TDG’s commercial OEM channel; production ramp is real but supply chain constraints at higher rates are a watch item.
Read-Through: Positive for TDG’s defense channel; LHX’s missile business ramp and supply chain investment signal sustained multi-year defense demand.
Overall Peer Read-Through Summary: The weight of peer evidence is constructive to bullish for TDG’s Q3 FY2026 print. Commercial aftermarket demand is accelerating (not decelerating) across RTX, GE, and HEICO; OEM production rates are ramping as expected; defense bookings are at record levels; and the Middle East disruption is being characterized as transitory by every peer. The only watch item is supply chain constraints at very high OEM production rates (Boeing commentary), which is a 2027+ issue rather than a Q3 FY2026 risk.
Key Takeaway: The most important post-Q2 development is the Stellant withdrawal (July 13) — while initially a negative signal, it freed capital that was quickly redeployed into the Prince & Izant acquisition (July 27), demonstrating continued M&A discipline and pipeline depth. The net effect is capital allocation optionality, not a strategic setback.
Key Takeaway: All insider transactions since the Q2 print are routine 10b5-1 plan executions — option exercises followed by same-day sales (cashless exercise pattern). There are no discretionary open-market buys or sells, and no unusual clustering or size that would signal a directional view. The absence of discretionary activity is neutral.
Name | Title | Transaction Type | Shares | Transaction Date | Note |
Howley W Nicholas | Director | 10b5-1 Option Exercise + Sale | 10,132 shares exercised; 10,132 sold | July 20, 2026 | Routine 10b5-1 plan; cashless exercise of stock options via Howley Family Trust; no discretionary signal |
Reiss Joel | Co-Chief Operating Officer | 10b5-1 Option Exercise + Sale | 3,900 shares exercised; 3,486 + 414 sold | July 15, 2026 | Routine 10b5-1 plan; cashless exercise; net shares retained after tax withholding; no discretionary signal |
Howley W Nicholas | Director | 10b5-1 Option Exercise + Sale | 10,132 shares exercised; 10,132 sold (multiple tranches) | June 18, 2026 | Routine 10b5-1 plan; cashless exercise via Howley Family Trust; consistent with prior months’ pattern |
Reiss Joel | Co-Chief Operating Officer | 10b5-1 Option Exercise + Sale | 3,900 shares exercised; 3,900 sold | June 15, 2026 | Routine 10b5-1 plan; cashless exercise; consistent monthly cadence |
Howley W Nicholas | Director | 10b5-1 Option Exercise | 10,132 shares acquired (Common Stock) | May 18, 2026 | Routine 10b5-1 plan; option exercise only (no same-day sale filed in this tranche); Howley Family Trust |
Reiss Joel | Co-Chief Operating Officer | 10b5-1 Option Exercise | 3,900 shares acquired (Common Stock) | May 15, 2026 | Routine 10b5-1 plan; option exercise; consistent with prior months’ cadence |
Assessment: All transactions are pre-scheduled 10b5-1 plan executions (option exercises followed by same-day or near-term sales), consistent with a regular monthly cadence for both Howley and Reiss. The overall_10b5 flag is True for all transactions. There are no open-market discretionary buys or sells, no unusual clustering, and no large block sales outside the plan. This is a neutral signal — insiders are not adding to positions, but they are not making discretionary sales either.
Source: Insider Transaction Data (SEC Form 4 filings, May 5 – August 3, 2026).